Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
43 Cards in this Set
- Front
- Back
Which ovarian cancer has LDH as a tumor marker?
|
dysgerminoma
|
|
Which ovarian cancers have AFP as tumor markers?
|
embryonal and yolk sac (endodermal sinus)
|
|
Which ovarian cancer has hcg as a tumor marker?
|
choriocarcinoma
|
|
Which ovarian tumor is made from fetal tissues?
|
teratoma
|
|
Which ovarian tumor is made from placental tissues?
|
choriocarcinoma
|
|
high bhcg can cause what sx
|
n/v
dizziness, photophobia (preeclamptic sx) tremors, nervousness (hyperthyroid sx) |
|
most common sx of GTD
|
irregular or heavy bleeding during early pregancy
|
|
bilateral theca lutein cysts ass w/ ?
|
complete molar pregnancy (high bhcg)
|
|
tx for molar pregnancy
|
remove tissue with D&E
curetage Rhogam for mother follow bhcg to zero (8-14 weeks), prevent pregnancy during this period |
|
What percent of molar pregnancies develop persistent / invasive type?
|
20%
|
|
Most common mets site of GTD malignancy
|
lungs !
vagina / pelvis second brain |
|
Treatment for malignant GTD?
|
It is sensitive to chemotherapy.
methotrexate or actinomycin-D; Outside of US, etoposide and 5-FU are used. |
|
Poor prognosis malignant GTD receives multiple-agent chemo. What drugs are used in the common regimens?
|
EMA-CO
etoposide methotrexate actinomycin ctyoxan oncovin (vincristine) |
|
How are persistent moles diagnosed?
|
bhcg continues to rise after evacuation
|
|
Tx for persistent moles
|
methotrexate or actinomycin D
|
|
Where is choriocarcinoma a leading form of gyn cancer?
|
Africa
|
|
T/F Choriocarcinoma can arise after a normal gestation as well as a molar pregnancy.
|
true (25%)
another 25% follows SAB and ectopic |
|
milk letdown is caused by ?
|
oxytocin
|
|
ductal development and fat deposition of breast regulated by ?
|
estrogen
|
|
lobular-alveolar development of breast for lactation regulated by ?
|
progesterone
|
|
definition of lumpectomy vs. excisional biopsy
|
lumpectomy has 1 cm margin, so if it's malignant nothing more need be done.
|
|
bloody nipple discharge, suspect ?
|
intraductal papilloma or invasive papillary cancer
|
|
yellow nipple discharge, suspect ?
|
galactorrhea or fibrocystic change
|
|
green sticky nipple discharge, suspect ?
|
duct ectasia; fibrocystic change can also produce green nonsticky discharge
|
|
T/F Breast pain is rarely a sign of cancer.
|
true
|
|
Beside vitamin supplementation, what are some medical treatments that may help fibrocystic change?
|
bromocriptine
danazol progestins tamoxifen evening primrose oil |
|
A large fibroadenoma may be ?
|
cystosarcoma phylllodes
|
|
workup and tx for fibroadenoma?
|
FNA
follow clinically if no fam hx of breast cancer |
|
workup and tx for cystosarcoma phyllodes?
|
10% malignant;
wide local excision for very large, mastectomy |
|
Tx for intraductal papilloma and duct ectasia
|
excision of ducts
|
|
?% of breast tumors in reproductive age women are benign
? % of breast tumors in perimenopausal women are malignant |
66%
50% |
|
T/F Alcohol abuse increases the risk of breast cancer.
|
true
|
|
What is the mnemonic for breast cancer treatment steps?
|
CLaRA-AM
1. Conservation vs mastectomy 2. Lymph node status 3. Receptor status (hormone receptor) 4. Age and menopause status (premen usually receptor negative, postmen usually receptor positive) 5. Adjuvants needed 6. Mets treatment |
|
How are lymph nodes assessed in breast cancer?
|
sentinel lymph node biopy- inject ink to find the first LN, excise and examine, full LN dissection if positive
|
|
Positive hormone receptor status means the tumor and prognosis are ?
|
tumor is well differentiated
prognosis is better; can treat with tamoxifen |
|
If lymph nodes are positive in breast cancer assessment, what adjuvant treatment do you assign?
|
CMF chemo
cyclophosphamide methotrexate 5-FU |
|
If hormone receptors are negative, in breast cancer assessment, what adjuvant treatment do you assign?
|
chemotherapy
maybe CMF? |
|
If hormone receptors are positive in breast cancer assessment, what adjuvant treatment do you assign?
|
tamoxifen
|
|
What treatment for breast cancer METS if estrogen receptor negative?
|
AV: adriamycin (doxycycline) and vincristine
|
|
What treatment for breast cancer METS if estrogen receptor positive?
|
tamoxifen if postmenopausal
GnRH antagonists if premenopausal |
|
What is the most reliable predictor of breast cancer survival?
|
state at diagnoses
1- 80% 2- 60% 3- 20% 4 - minimal |
|
What is followup for breast cancer tx?
|
q 3 months first year
q 4 months second year q 6 months afterward mammograms every 6 months blood tests for alk phos (bone dz) and LFTs every 6 months |
|
T/F Pregnancy after breast cancer tx is contraindicated b/c of estrogen effects.
|
False. No difference in survival rates, no adverse effects of OCPs. Probably no difference in survival rates with HRT.
|